Abstract Pancreatic cancer is a lethal disease with poor prognosis. Gemcitabine has been the first line systemic treatment for pancreatic cancer. However. the rapid development of drug resistance has been a major hurdle in gemcitabine therapy leading to unsatisfactory patient outcomes. https://www.markbroyard.com/super-save-whole-wheat-phyllo-pastry-sheets-jufka-sa-integralnim-brasnom-12pcs-x-450g-jami-supply-great-choice/